Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Tue, 09/5/23 - 11:25 am
Tags:
Novo Nordisk, UK, Wegovy, obesity
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Clinical Trials Arena
Fri, 09/1/23 - 12:18 pm
Tags:
Novo Nordisk, Wegovy, Ozempic, Denmark
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Tags:
Novo Nordisk, Wegovy, Ozempic, cardiovascular disease
Are weight loss drugs a win for the global economy?
Pharma Voice
Thu, 08/31/23 - 10:14 am
Tags:
Novo Nordisk, Wegovy, weight loss, Ozempic
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Thu, 08/31/23 - 10:11 am
Tags:
Senate, insulin, drug pricing, Novo Nordisk, Eli Lilly, Sanofi, diabetes
Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
BioSpace
Wed, 08/30/23 - 11:22 am
Tags:
Novo Nordisk, Embark Biotech, obesity, M&A
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
Investopedia
Wed, 08/30/23 - 10:03 am
Tags:
Catalent, Wegovy, Novo Nordisk, Elliott Management
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare, HHS, Pfizer, Bristol Myers Squibb, Eli Lilly, Boehringer Ingelheim, AstraZeneca, AbbVie, Novo Nordisk, JNJ, drug pricing
Why Wegovy's Sales Potential Could Be Massively Understated
Motley Fool
Tue, 08/29/23 - 11:08 am
Tags:
Novo Nordisk, Wegovy, heart attack, stroke
Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says
Fierce Pharma
Mon, 08/28/23 - 08:00 pm
Tags:
Novo Nordisk, weight loss, Wegovy, Ozempic
On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure
Fierce Pharma
Fri, 08/25/23 - 11:54 am
Tags:
Novo Nordisk, Wegovy, heart failure, clinical trials
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says
Forbes
Fri, 08/25/23 - 09:48 am
Tags:
Novo Nordisk, Wegovy, Lars Fruergaard Jorgensen, weight loss
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Tags:
Novo Nordisk, Ozempic, diabetes, weight loss, liver disease, addiction, cardiovascular disease
Novo Nordisk enlists Thermo Fisher as second Wegovy manufacturer: report
Medical Marketing and Media
Wed, 08/23/23 - 05:38 pm
Tags:
Novo Nordisk, Thermo Fisher, drug manufacturing, Wegovy
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
Tags:
earnings, Eli Lilly, JNJ, Novo Nordisk, Novartis, AstraZeneca
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
Forbes
Mon, 08/21/23 - 10:38 am
Tags:
weight loss, Novo Nordisk, Wegovy, Ozempic
Demand for weight loss drugs soars to nearly half of Americans
Pharma Voice
Wed, 08/16/23 - 10:14 am
Tags:
weight loss, Novo Nordisk, Ozempic
Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2
Fierce Pharma
Wed, 08/16/23 - 10:05 am
Tags:
Novo Nordisk, Eli Lilly, obesity, diabetes, earnings
Novo Nordisk prolongs rationing Wegovy solutions
Beckers Hospital Review
Thu, 08/10/23 - 09:59 pm
Tags:
Novo Nordisk, Wegovy, drug rationing, drug shortages
Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Tags:
Novo Nordisk, M&A, obesity, Inversago

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.